Literature DB >> 21097820

Performance of the ASSIGN cardiovascular disease risk score on a UK cohort of patients from general practice.

Beatriz de la Iglesia1, John F Potter, Neil R Poulter, Margaret M Robins, Jane Skinner.   

Abstract

OBJECTIVE: To evaluate the performance of ASSIGN against the Framingham equations for predicting 10 year risk of cardiovascular disease in a UK cohort of patients from general practice and to make the evaluation comparable to an independent evaluation of QRISK on the same cohort.
DESIGN: Prospective open cohort study. Setting 288 practices from England and Wales contributing to The Health Improvement Network (THIN) database. PARTICIPANTS: Patients registered with 288 UK practices for some period between January 1995 and March 2006. The number of records available was 1,787,169. MAIN OUTCOME MEASURES: First diagnosis of myocardial infarction, coronary heart disease, stroke and transient ischaemic attacks recorded. Methods We implemented the Anderson Framingham Coronary Heart Disease and Stroke models, ASSIGN, and a more recent Framingham Cox proportional-hazards model and analysed their calibration and discrimination.
RESULTS: Calibration showed that all models tested over-estimated risk particularly for men. ASSIGN showed better discrimination with higher AUROC (0.756/0.792 for men/women), D statistic (1.35/1.58 for men/women), and R²(30.47%/37.39% for men/women). The performance of ASSIGN was comparable to that of QRISK on the same cohort. Models agreed on 93-97% of categorical (high/lower) risk assessments and when they disagreed, ASSIGN was often closer to the estimated Kaplan-Meier incidence. ASSIGN also provided a steeper gradient of deprivation and discriminated between those with and without recorded family history of CVD. The estimated incidence was twice/three times as high for women/men with a recorded family history of CVD.
CONCLUSIONS: For systematic CVD risk assessment all models could usefully be applied, but ASSIGN improved on the gradient of deprivation and accounted for recorded family history whereas the Framingham equations did not. However, all models display relatively low specificity and sensitivity. An additional conclusion is that the recording of family history of CVD in primary care databases needs to improve given its importance in risk assessment.

Entities:  

Mesh:

Year:  2010        PMID: 21097820     DOI: 10.1136/hrt.2010.203364

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  9 in total

Review 1.  Cardiovascular risk.

Authors:  Rupert A Payne
Journal:  Br J Clin Pharmacol       Date:  2012-09       Impact factor: 4.335

2.  Does inclusion of education and marital status improve SCORE performance in central and eastern europe and former soviet union? findings from MONICA and HAPIEE cohorts.

Authors:  Olga Vikhireva; Grazyna Broda; Ruzena Kubinova; Sofia Malyutina; Andrzej Pająk; Abdonas Tamosiunas; Zdena Skodova; Galina Simonova; Martin Bobak; Hynek Pikhart
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

3.  Availability and quality of coronary heart disease family history in primary care medical records: implications for cardiovascular risk assessment.

Authors:  Paula Dhiman; Joe Kai; Laura Horsfall; Kate Walters; Nadeem Qureshi
Journal:  PLoS One       Date:  2014-01-09       Impact factor: 3.240

4.  Independent external validation of cardiovascular disease mortality in women utilising Framingham and SCORE risk models: a mortality follow-up study.

Authors:  Louise Gek Huang Goh; Timothy Alexander Welborn; Satvinder Singh Dhaliwal
Journal:  BMC Womens Health       Date:  2014-09-26       Impact factor: 2.809

5.  18F-Fluoride and 18F-Fluorodeoxyglucose Positron Emission Tomography After Transient Ischemic Attack or Minor Ischemic Stroke: Case-Control Study.

Authors:  Alex T Vesey; William S A Jenkins; Agnese Irkle; Alastair Moss; Greg Sng; Rachael O Forsythe; Tim Clark; Gemma Roberts; Alison Fletcher; Christophe Lucatelli; James H F Rudd; Anthony P Davenport; Nicholas L Mills; Rustam Al-Shahi Salman; Martin Dennis; William N Whiteley; Edwin J R van Beek; Marc R Dweck; David E Newby
Journal:  Circ Cardiovasc Imaging       Date:  2017-03       Impact factor: 7.792

6.  Nomogram Based on Cytokines for Cardiovascular Diseases in Xinjiang Kazakhs.

Authors:  Lei Mao; Xianghui Zhang; Yunhua Hu; Xinping Wang; Yanpeng Song; Jia He; Wenwen Yang; Jiaolong Ma; Yizhong Yan; Lati Mu; Jingyu Zhang; Kui Wang; Heng Guo; Rulin Ma; Shuxia Guo
Journal:  Mediators Inflamm       Date:  2019-05-05       Impact factor: 4.711

Review 7.  Cardiovascular Risk Prediction Models and Scores in the Era of Personalized Medicine.

Authors:  Areti Sofogianni; Nikolaos Stalikas; Christina Antza; Konstantinos Tziomalos
Journal:  J Pers Med       Date:  2022-07-20

8.  Metabolic syndrome in Xinjiang Kazakhs and construction of a risk prediction model for cardiovascular disease risk.

Authors:  Lei Mao; Jia He; Xiang Gao; Heng Guo; Kui Wang; Xianghui Zhang; Wenwen Yang; Jingyu Zhang; Shugang Li; Yunhua Hu; Lati Mu; Yizhong Yan; Jiaolong Ma; Yusong Ding; Mei Zhang; Jiaming Liu; Rulin Ma; Shuxia Guo
Journal:  PLoS One       Date:  2018-09-06       Impact factor: 3.240

9.  Evaluating Cardiovascular Disease (CVD) risk scores for participants with known CVD and non-CVD in a multiracial/ethnic Caribbean sample.

Authors:  Amalia Hosein; Valerie Stoute; Samantha Chadee; Natasha Ramroop Singh
Journal:  PeerJ       Date:  2020-03-09       Impact factor: 2.984

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.